FDA Petition Seeks DTC Drug Ad Ban: What Clinicians Need to Know

References

1. 1.Silverman, E. (2026, July 23). FDA is urged by advocacy group to ban DTC prescription drug ads. STAT News (Pharmalot). https://www.statnews.com/pharmalot/2026/07/23/fda-urged-by-advocacy-group-to-ban-dtc-prescription-drug-ads/
2. 2.Ventola, C. L. (2011). Direct-to-consumer pharmaceutical advertising: Therapeutic or toxic? Pharmacy and Therapeutics, 36(10), 669–684. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3278148/
3. 3.Kravitz, R. L., Epstein, R. M., Feldman, M. D., Franz, C. E., Azari, R., Wilkes, M. S., Hinton, L., & Franks, P. (2005). Influence of patients' requests for direct-to-consumer advertised antidepressants: A randomized controlled trial. JAMA, 293(16), 1995–2002. https://doi.org/10.1001/jama.293.16.1995
4. 4.Schwartz, L. M., & Woloshin, S. (2019). Medical marketing in the United States, 1997–2016. JAMA, 321(1), 80–96. https://doi.org/10.1001/jama.2018.19320
5. 5.Therapeutic Goods Administration. (2021). Therapeutic Goods Advertising Code 2021. Australian Government Federal Register of Legislation. https://www.legislation.gov.au/Details/F2021L00479
6. 6.Donohue, J. (2006). A history of drug advertising: The evolving roles of consumers and consumer protection. Milbank Quarterly, 84(4), 659–699. https://doi.org/10.1111/j.1468-0009.2006.00464.x
7. 7.Frosch, D. L., Grande, D., Tarn, D. M., & Kravitz, R. L. (2010). A decade of controversy: Balancing policy with evidence in the regulation of prescription drug advertising. American Journal of Public Health, 100(1), 24–32. https://doi.org/10.2105/AJPH.2008.153767
8. 8.Toop, L., & Richards, D. (2003). Direct to consumer advertising of prescription drugs in New Zealand: For health or for profit? New Zealand Medical Journal, 116(1180), U574. https://www.nzma.org.nz/journal-articles/direct-to-consumer-advertising-of-prescription-drugs-in-new-zealand-for-health-or-for-profit